Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,231 public trials 1,018 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

NCT00966914

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Birmingham, Alabama, United States
  • Columbia, Missouri, United States
  • Philadelphia, Pennsylvania, United States
  • Germantown, Tennessee, United States
View all 42 locations
View Trial Details
Completed

Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer

NCT00553800

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • AtlantiCare Regional Medical Center Galloway, New Jersey, United States
  • Fox Chase Virtua Health Cancer Program at Memorial Mount Holly, New Jersey, United States
  • Paoli Hospital Paoli, Pennsylvania, United States
  • Abramson Cnacer Center, University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C

NCT03623750

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Hospital Universitario Insular de Gran Canaria Las Palmas de Gran Canaria, Canary Islands, Spain
  • Instituto Oncológico Dr. Rosell Barcelona, Spain
  • Hospital Clínic Barcelona Barcelona, Spain
  • Hospital Universitario Regional de Málaga Málaga, Spain
View Trial Details
Completed

Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors

NCT03102320

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford Health Care Stanford, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 72 locations
View Trial Details
Completed

Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)

NCT00097851

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Sydney Cancer Centre, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Sydney Haematology and Oncology Clinics Hornsby, New South Wales, Australia
  • Prince of Wales Hospital Randwick, New South Wales, Australia
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
View all 13 locations
View Trial Details
Completed

Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies

NCT02648724

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 27 locations
View Trial Details

Related conditions